PATENT CASE OF THE WEEK -
Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories, FL, Inc., Appeal No. 2018-1221 (Fed. Cir. Aug. 15, 2019) -
This week’s Case of the Week focuses on issues relating to written...more
8/20/2019
/ Abbreviated New Drug Application (ANDA) ,
Claim Construction ,
Claim Limitations ,
Hatch-Waxman ,
Motion to Amend ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Section 101 ,
Written Descriptions
Texas Advanced Optoelectronic Solutions, Inc. v. Renesas Electronics America, Inc., Appeal Nos. 2016-2121, -2208, -2235 (Fed. Cir. 2018)?-
In an appeal from a jury trial, the Federal Circuit addressed numerous issues...more
5/8/2018
/ Appeals ,
Arbitrary and Capricious ,
Attorney's Fees ,
Breach of Contract ,
Constitutional Challenges ,
Disclosure ,
Disgorgement ,
Dismissal With Prejudice ,
Enhanced Damages ,
Experimental Use Exception ,
Inequitable Conduct ,
Intellectual Property Protection ,
Interference Proceeding ,
Inventions ,
Inventors ,
Irreparable Harm ,
Misappropriation ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patent Trial and Appeal Board ,
Patents ,
Permanent Injunctions ,
Public Use ,
Remand ,
Reversal ,
Right to a Jury ,
Seventh Amendment ,
Tortious Interference ,
Trade Secrets ,
Twombly/Iqbal Pleading Standard ,
USPTO ,
Vacated ,
Written Descriptions
PATENT CASE OF THE WEEK -
SimpleAir, Inc. v. Google LLC, Appeal No. 2016-2738 (Fed. Cir. 2018) -
In SimpleAir, Inc. v Google LLC, the Federal Circuit vacated a district court’s motion to dismiss pursuant to Rule...more
3/20/2018
/ Appeals ,
Claim Construction ,
Claim Preclusion ,
Collateral Estoppel ,
Double Patent ,
Federal Rule 12(b)(6) ,
Inter Partes Review (IPR) Proceeding ,
Kessler Doctrine ,
Motion to Dismiss ,
Noninfringement ,
Obviousness ,
Parent Patents ,
Patent Applications ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Reversal ,
Terminal Disclaimer ,
USPTO ,
Written Descriptions